Trials / Completed
CompletedNCT00619073
PACT (Platelet Activity After Clopidogrel Termination)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- University of Massachusetts, Worcester · Academic / Other
- Sex
- All
- Age
- 21 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
Clopidogrel is a medication that is used to decrease the ability of platelets to form blood clots. The theory has been proposed that, in patients with coronary artery disease or stroke, increased platelet function after discontinuation of clopidogrel therapy is associated with an increased clotting risk. However, this theory has never been rigorously tested. The goal of this research is to determine whether discontinuation of clopidogrel results in increased platelet function.
Detailed description
In this study, we will address the question: does discontinuation of clopidogrel result in platelet hyperreactivity? We will perform a double-blind, placebo-controlled, crossover study in normal subjects, in whom platelet reactivity will be measured before clopidogrel or placebo, during clopidogrel or placebo, and at various time points after discontinuation of clopidogrel or placebo. The dose of clopidogrel will be the standard, FDA-approved dose: 75 mg daily. All subjects will be treated with aspirin 81 mg daily throughout the 57 days of study assessment in both the clopidogrel arm and the placebo arm, because the clinically relevant question is: in patients who remain on aspirin, does discontinuation of clopidogrel result in platelet hyperreactivity?
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | clopidogrel + aspirin | Clopidogrel 75mg plus aspirin 81mg, tablet by mouth daily for 14 days. |
| DRUG | placebo | Placebo plus aspirin 81 mg, tablet by mouth daily for 14 days. |
| DRUG | Aspirin | Aspirin 81mg tablet by mouth continued daily alone for 43 days after day 14. |
Timeline
- Start date
- 2008-04-01
- Primary completion
- 2009-05-01
- Completion
- 2009-05-01
- First posted
- 2008-02-20
- Last updated
- 2018-05-31
- Results posted
- 2012-11-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00619073. Inclusion in this directory is not an endorsement.